Tags

Type your tag names separated by a space and hit enter

Comparative probiotic strain efficacy in the prevention of eczema in infants and children: a systematic review and meta-analysis.
Mil Med. 2014 Jun; 179(6):580-92.MM

Abstract

BACKGROUND

Eczema affects 3.5% of the global population, with peak prevalence during infancy. Eczema has no cure, but probiotics have been suggested as a preventative measure.

OBJECTIVE

To comprehensively analyze the impact of prenatal and postnatal probiotic supplementation on the prevention of infantile and childhood eczema.

METHODS

MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and PubMed were searched for randomized controlled trials regarding probiotic usage and eczema development from 1945 to 2013. Participants included were 7 years old or younger with probiotic exposure in utero or below 6 months of age and who was not diagnosed previously.

RESULTS

27 publications describing 16 studies assessing 10 probiotics in 2,797 participants met our criterion. The pooled relative risk of all the studies, 0.74 (95% confidence interval 0.67, 0.82), indicated that probiotic supplementation in the first several years of life did have a significant impact on development of eczema. During evaluation of the studies, heterogeneity of terms and definitions for similar primary and secondary outcomes were identified.

CONCLUSION

The use of probiotic supplements during pregnancy and/or during infancy creates a statistically significant decline in the incidence of eczema. The heterogeneity of terms and definitions regarding eczema is the major limitation of these studies.

Authors+Show Affiliations

F. Edward Hebert School of Medicine, Uniformed Services University of Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814.F. Edward Hebert School of Medicine, Uniformed Services University of Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814.F. Edward Hebert School of Medicine, Uniformed Services University of Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814.Department of Preventative Medicine and Biometrics, Uniformed Services University of Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814.

Pub Type(s)

Comparative Study
Journal Article
Meta-Analysis
Review
Systematic Review

Language

eng

PubMed ID

24902123

Citation

Mansfield, Joseph A., et al. "Comparative Probiotic Strain Efficacy in the Prevention of Eczema in Infants and Children: a Systematic Review and Meta-analysis." Military Medicine, vol. 179, no. 6, 2014, pp. 580-92.
Mansfield JA, Bergin SW, Cooper JR, et al. Comparative probiotic strain efficacy in the prevention of eczema in infants and children: a systematic review and meta-analysis. Mil Med. 2014;179(6):580-92.
Mansfield, J. A., Bergin, S. W., Cooper, J. R., & Olsen, C. H. (2014). Comparative probiotic strain efficacy in the prevention of eczema in infants and children: a systematic review and meta-analysis. Military Medicine, 179(6), 580-92. https://doi.org/10.7205/MILMED-D-13-00546
Mansfield JA, et al. Comparative Probiotic Strain Efficacy in the Prevention of Eczema in Infants and Children: a Systematic Review and Meta-analysis. Mil Med. 2014;179(6):580-92. PubMed PMID: 24902123.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparative probiotic strain efficacy in the prevention of eczema in infants and children: a systematic review and meta-analysis. AU - Mansfield,Joseph A, AU - Bergin,Samuel W, AU - Cooper,James R, AU - Olsen,Cara H, PY - 2014/6/6/entrez PY - 2014/6/6/pubmed PY - 2015/9/1/medline SP - 580 EP - 92 JF - Military medicine JO - Mil Med VL - 179 IS - 6 N2 - BACKGROUND: Eczema affects 3.5% of the global population, with peak prevalence during infancy. Eczema has no cure, but probiotics have been suggested as a preventative measure. OBJECTIVE: To comprehensively analyze the impact of prenatal and postnatal probiotic supplementation on the prevention of infantile and childhood eczema. METHODS: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and PubMed were searched for randomized controlled trials regarding probiotic usage and eczema development from 1945 to 2013. Participants included were 7 years old or younger with probiotic exposure in utero or below 6 months of age and who was not diagnosed previously. RESULTS: 27 publications describing 16 studies assessing 10 probiotics in 2,797 participants met our criterion. The pooled relative risk of all the studies, 0.74 (95% confidence interval 0.67, 0.82), indicated that probiotic supplementation in the first several years of life did have a significant impact on development of eczema. During evaluation of the studies, heterogeneity of terms and definitions for similar primary and secondary outcomes were identified. CONCLUSION: The use of probiotic supplements during pregnancy and/or during infancy creates a statistically significant decline in the incidence of eczema. The heterogeneity of terms and definitions regarding eczema is the major limitation of these studies. SN - 1930-613X UR - https://www.unboundmedicine.com/medline/citation/24902123/Comparative_probiotic_strain_efficacy_in_the_prevention_of_eczema_in_infants_and_children:_a_systematic_review_and_meta_analysis_ L2 - https://academic.oup.com/milmed/article-lookup/doi/10.7205/MILMED-D-13-00546 DB - PRIME DP - Unbound Medicine ER -